Odevixibat (A4250) is a selective and orally active ileal apical sodium-dependent bile acid transporter (ASBT) inhibitor. Odevixibat decreases cholestatic liver and bile duct injury in mice model. Odevixibat has the potential for the treatment of primary biliary cirrhosis[1].
Molecular Weight:
740.93
Purity:
99.88
CAS Number:
[501692-44-0]
Formula:
C37H48N4O8S2
Target:
Apical Sodium-Dependent Bile Acid Transporter
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted